Spectral Medical Inc. Closes C$6.1 Million Bought Deal Convertible Note Financing - The Globe and Mail
Spectral Medical Inc. closed a private placement of 9.0% convertible notes, raising US$4,553,000 for its Tigris Study on PMX treatment for septic shock. Patient enrollment reached 72, aiming for 90 by end of 2023. Baxter International Inc. supported the funding, aligning with Spectral's strategy for FDA approval.
Reference News
Spectral Medical Inc. Closes C$6.1 Million Bought Deal Convertible Note Financing - The Globe and Mail
Spectral Medical Inc. closed a private placement of 9.0% convertible notes, raising US$4,553,000 for its Tigris Study on PMX treatment for septic shock. Patient enrollment reached 72, aiming for 90 by end of 2023. Baxter International Inc. supported the funding, aligning with Spectral's strategy for FDA approval.